COMPANY OVERVIEW Narayana Hrudayalaya Limited (formerly known as Narayana Hrudayalaya Private Limited) ('the Company') was incorporated on 19 July 2000 under the Companies Act, 1956. The Company, headquartered in Bengaluru is engaged in providing economical healthcare services. The Company was rebranded as 'Narayana Health' in 2013. It has a network of multispecialty and superspeciality hospitals sbrad across multiple locations. The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. During the year ended 31 March 2016, the Company completed the Initial Public Offering (IPO) through an offer for sale by existing shareholders to the extent of Rs.24,523,297 equity shares of face value of Rs. 10 each for a cash price of f 250 per equity share including a brmium of f 240 per equity share, of 6,287,978 equity shares by Ashoka Investment Holdings Limited, Rs. 1,886,455 equity shares by Ambadevi Mauritius Holdings Limited, 12,261,648 equity shares by JP Morgan Mauritius Holdings IV Limited, Rs.2,043,608 equity shares by Dr. Devi Prasad Shetty and 2,043,608 equity shares by Shakuntala Shetty aggregating to Rs. 6,130.82 million and the equity shares of the Company were listed on the BSE Limited and the National Stock Exchange of India Limited on 6 January 2016. 1. SIGNIFICANT ACCOUNTING POLICIES 1.1 Basis of brparation of standalone financial statements These standalone financial statements are brpared in accordance with Indian Generally Accepted Accounting Principles (GAAP) under the historical cost convention on the accrual basis of accounting and comply with accounting standards brscribed under Section 133 of the Companies Act, 2013 (''the Act'') read with Rule 7 of the Companies (Accounts) Rules, 2014, other pronouncements of the Institute of Chartered Accountants of India ('ICAI'), and the provisions of the Act to the extent notified and applicable. The accounting policies adopted in the brparation of the standalone financial statements are consistent with those followed in the brvious year. The standalone financial statements are brsented in Indian Rupees (f). 1.2 Use of estimates The brparation of standalone financial statements in conformity with generally accepted accounting principles in India requires the management to make judgement, estimates and assumptions that affect the application of accounting policies and reported amounts of assets, liabilities, income and expenses and the disclosure of contingent liabilities on the date of the financial statements. Actual results could differ from those estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Any revision to accounting estimates is recognised prospectively in the current and future years. 1.3 Current and non - current classification All assets and liabilities are classified into current and non - current. Assets An asset is classified as current when it satisfies any of the following criteria: (a) It is expected to be realised in, or is intended for sale or consumption in, the Company's normal operating cycle; (b) It is held primarily for the purpose of being traded; (c) It is expected to be realised within 12 months after the reporting date; or (d) I t is cash or cash equivalent unless it is restricted from being exchanged or used to settle a liability for at least 12 months after the reporting date. (e) Current assets include the current portion of non - current financial assets. (f) All other assets are classified as non current. Liabilities A liability is classified as current when it satisfies any of the following criteria: a) It is expected to be settled in the Company's normal operating cycle; b) It is held primarily for the purpose of being traded; c) It is expected to be settled within 12 months after the reporting date; or d) The Company does not have an unconditional right to defer settlement of the liability for at least 12 months after the reporting date. Terms of a liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification. Current liabilities include the current portion of non - current financial liabilities. All other liabilities are classified as non -current. Operating cycle Operating cycle is the time between the acquisition of assets for processing and their realizations in cash or cash equivalents. 1.4 Inventories The inventories of medical consumables, drugs and surgical equipments are valued at lower of cost or net realisable value. In the absence of any further estimated costs of completion and estimated costs necessary to make the sale, the net realisable value is the selling price. Cost of these inventories comprises of all costs of purchase and other costs incurred in bringing the inventories to their brsent location after adjusting for value added tax wherever applicable, applying the first in first out method. 1.5 Cash and cash equivalents Cash comprises cash on hand and demand deposits with banks. Cash equivalents are short-term balances (with an original maturity of three months or less from the date of acquisition), highly liquid investments that are readily convertible into known amounts of cash and which are subject to insignificant risk of changes in value 1.6 Cash flow statement Cash flows are reported using the indirect method, whereby net profit before tax is adjusted for the effects of transactions of a non-cash nature and any deferrals or accruals of past or future cash receipts or payments. The cash flows from operating, investing and financing activities of the Company are segregated. 1.7 Fixed assets, debrciation and amortisation Fixed assets are stated at the cost of acquisition or construction less accumulated debrciation. The cost of fixed assets not ready for their use before such date, are disclosed as capital work in progress. Advances paid towards acquisition of fixed assets outstanding as of the balance sheet date are disclosed under long-term loans and advances. (a) Tangible fixed assets Tangible fixed assets are carried at cost of acquisition or construction less accumulated debrciation and/ or accumulated impairment, if any. The cost of an item of tangible fixed assets comprises its purchase price, including import duties and other non-refundable taxes or levies, freight and any directly attributable cost of bringing the asset to its working condition for its use; any trade discounts and rebates are deducted in arriving at the purchase price. Subsequent expenditures related to an item of tangible fixed asset are added to its book value only if they increase the future benefits from the existing asset beyond its brviously assessed standard of performance. (b) Intangible fixed assets Intangible assets are recorded at consideration paid for acquisition of such assets and are carried at cost less accumulated amortization and accumulated impairment loss, if any. Intangible assets are assessed for impairment whenever there is an indication that the intangible asset may be impaired. (c) Debrciation and amortization Leasehold improvements are being amortised over the term of the lease, or estimated useful life of the assets, whichever is lower. Consideration paid for acquiring leasehold land is amortized over the lease term. Freehold land is not debrciated. Debrciation on additions and disposals during the year is provided on proportionate basis. The Company believes that the useful life as given above best rebrsent the useful life of the assets based on the internal technical assessment and these useful life are as brscribed under Part C of Schedule II of the Companies Act, 2013 except vehicles where useful life considered by management is lower. Fixed assets that have been retired from active use and are held for disposal are stated at the lower of their net book value and net realizable value and are shown under "other current assets'' 1.8 Revenue recognition Revenue from operations Revenue from medical and healthcare services to patients is recognised as revenue when the related services are rendered unless significant future uncertainties exist. Revenue is also recognised in relation to the services rendered to the patients who are undergoing treatment/observation on the balance sheet date to the extent of services rendered. Revenue is recognised net of discounts given to the patients. Revenue from sale of medical consumables and drugs within the hospital brmises is recognised when property in the goods or all significant risks and rewards of their ownership are transferred to the customer and no significant uncertainty exists regarding the amount of the consideration that will be derived from the sale of the goods and regarding its collection. The Company has entered into management agreements with certain trusts, under which, the Company has a right over the management, operation and utilisation of hospital facilities owned by the trusts. As a consideration towards the aforesaid arrangement, the Company is obligated to offer discounts to patients nominated by the trusts at free of cost/ concession as per the terms of the agreement. The discounts thus offered have been recognised as revenue with a corresponding charge to rent expense. 'Unbilled revenue' rebrsents value to the extent of medical and healthcare services rendered to the patients who are undergoing treatment/observation on the balance sheet date and is not billed as at the balance sheet date. 'Unearned revenue' comprises billings in excess of earnings. Interest Interest on the deployment of funds is recognised using the time-proportion method, based on underlying interest rates. Dividend Dividend income is recognised when the Company's right to receive dividend is established. Learning and development income Revenue is recognized on pro-rata basis on the completion of such services over the duration of the program. 1.9 Government grants Government grants available to the Company are recognised (i) where there is reasonable assurance that the Company will comply with the conditions attached to them; and (ii) where such benefits have been earned by the Company and it is reasonably certain that the ultimate collection will be made. Government grants related to the acquisition or construction of fixed assets are shown as a deduction from the gross value of the respective fixed assets. 1.10 Borrowing cost Borrowing costs are interest and other costs incurred by the company in connection with the borrowing of funds. Borrowing costs directly attributable to acquisition or construction of those fixed assets which necessarily takes a substantial period of time to get ready for their use are capitalised. Other borrowing costs are accounted as an expense in the period in which they are incurred. 1.11 Investments Long term investments are carried at cost. Provision is made, wherever necessary, for any diminution, other than temporary, in value of investments. Current investments are carried at the lower of cost and fair value. The comparison of cost and fair value is determined separately for each individual investment. 1.12 Income tax Income-tax expense comprises of current tax (i.e. amount of tax for the year determined in accordance with the income-tax law) and deferred tax charge or credit (reflecting the tax effects of timing differences between accounting income and taxable income for the year). Minimum Alternate Tax ("MAT") paid in accordance with the tax laws which gives rise to future economic benefits in the form of adjustment of future income tax liability, is considered as an asset if there is convincing evidence that the Company will pay normal tax in subsequent years. MAT credit entitlement can be carried forward and utilised for a period of 10 years from the year in which the same is availed. Accordingly, it is recognised as an asset in the balance sheet when it is probable that the future economic benefit associated with it will flow to the Company and the asset can be measured reliably. The deferred tax charge or credit and the corresponding deferred tax liabilities or assets are recognised using the tax rates that have been enacted or substantively enacted by the balance sheet date. Deferred tax assets are recognized only to the extent there is reasonable certainty that the assets can be realised in future; however where there is unabsorbed debrciation or carried forward loss under taxation laws, deferred tax assets are recognised only if there is a virtual certainty of realisation of such assets. Deferred tax assets are reviewed as at each balance sheet date and written down or written-up to reflect the amount that is reasonably/virtually certain (as the case may be) to be realised. Assets and liabilities rebrsenting current tax and deferred tax are disclosed on a net basis where there is a legally enforceable right to set off and where the management intends to settle the asset and liability on a net basis. 1.13 Employee benefits Short term employee benefits Employee benefits payable wholly within 12 months of receiving services are classified as short-term employee benefits. These benefits include salary and wages, bonus and ex-gratia. The undiscounted amount of short-term employee benefits to be paid in exchange for employee services is recognized as an expense as the related service is rendered by the employees. Post-employment benefits Defined contribution plans A defined contribution plan is post-employment benefit plan under which an entity pays specified contributions to separate entity and has no obligation to pay any further amounts. The Company makes specified obligations towards employee provident fund and employee's state insurance to Government administered provident fund scheme and employee's state insurance scheme which is a defined contribution plan. The Company's contribution is recognized as an expense in the statement of profit and loss during the year in which the employee renders the related service. Defined benefit plans The Company's gratuity benefit scheme is a defined benefit plan. The Company's net obligation in respect of a defined benefit plan is calculated by estimating the amount of future benefit that employees have earned and returned for services in the current and prior periods; that benefit is discounted to determine its brsent value. The gratuity benefit of the company is administered by a trust formed for this purpose through the gratuity scheme. The Company's obligation in respect of the gratuity plan, which is a defined benefit plan, is provided for based on actuarial valuation carried out by an independent actuary using the projected unit credit method. The Company recognizes actuarial gains and losses periodically in the statement of profit and loss. All expenses related to defined benefit plans are recognized in employee benefit expense in the statement of profit and loss. When the benefits of a plan are improved, the portion of the increased benefit related to past service by employees is recognized in the statement of profit and Compensated absences The employees can carry-forward a portion of the unutilized accrued compensated absences and utilize it in future service periods or receive cash compensation on termination of employment. Since the employee has unconditional right to avail the leave, the benefit is classified as a short term employee benefit. The Company records an obligation for such compensated absences in the period in which the employee renders the services that increase this entitlement. The obligation is measured on the basis of actuarial valuation carried out by an independent actuary using the projected unit credit method. Employee Stock Option Plan (ESOP) The Company measures compensation cost relating to employee stock options using the intrinsic value method. Compensation expense, if any, is amortised over each vesting period on a straight line basis. 1.14 Earnings per share The basic earnings per share is computed by dividing the net profit attributable to equity shareholders for the year by the weighted average number of equity shares outstanding during the year. Diluted earnings per share is computed by dividing the net profit attributable to equity shareholders for the year relating to the dilutive potential equity shares, by the weighted average number of equity shares considered for deriving basic earnings per share and the weighted average number of equity shares which could have been issued on the conversion of all dilutive potential equity shares. Potential equity shares are deemed to be dilutive only if their conversion to equity shares would decrease the net profit per share. 1.15 Foreign exchange transactions and translations Foreign exchange transactions are recorded at the rate brvailing on the date of the transaction. Exchange differences arising on foreign exchange transactions settled during the year are recognised in the statement of profit and loss for the year except for exchange difference arising on settlement of long-term foreign currency monetary items (i.e. an asset or liability which is exbrssed in a foreign currency and has a term of 12 months or more at the date of the origination of the asset or liability) relating to acquisition of debrciable capital asset at rates different from those at which they were initially recorded during the year, or reported in brvious financial statements are added or deducted from the cost of the asset and shall be debrciated over the remaining life of the asset. Monetary assets and liabilities denominated in foreign currencies as at the balance sheet date are translated at the exchange rates on that date; the resultant exchange differences are recognised in the statement of profit and loss except for exchange difference arising on reporting of long-term foreign currency monetary items (i.e. an asset or liability which is exbrssed in a foreign currency and has a term of 12 months or more at the date of the origination of the asset or liability) relating to acquisition of debrciable capital asset at rates different from those at which they were initially recorded during the year, or reported in brvious financial statements, are added or deducted from the cost of the asset and shall be debrciated over the remaining life of the asset. 1.16 Leases Leases under which the Company assumes substantially all the risks and rewards of ownership are classified as finance leases. Such assets are capitalised at fair value of the asset or brsent value of the minimum lease payments at the inception of the lease, whichever is lower. Lease payments under operating lease are recognised as an expense in the statement of profit and loss on a straight line basis over the lease term. Lease term is the non-cancellable period for which the Company has agreed to take on lease the asset together with any further periods for which the Company has the option to continue the lease and at the inception of the lease it is reasonably certain that the Company will exercise such an option. The Company has entered into management agreements with certain trusts, under which, the Company has a right over the management, operation and utilisation of hospital facilities owned by the trusts. As a consideration towards the aforesaid arrangement, the Company is obligated to offer discounts to patients nominated by the trusts at free of cost/ concession as per the terms of the agreement. The discounts thus offered have been recognised as revenue with a corresponding charge to rent expense. 1.17 Provisions and contingencies Provision is recognised if, as a result of obligating events, there is a brsent obligation that probably requires an outflow of resources and a reliable estimate can be made of the amount of obligation. The disclosure of contingent liability is made if, as a result of obligating events, there is a possible obligation or a brsent obligation that may, but probably will not, require an outflow of resources. No provision or disclosure is made if, as a result of obligating events, there is a possible obligation or a brsent obligation where the likelihood of an outflow of resources is remote. Provisions for onerous contracts, i.e. contracts where the expected unavoidable costs of meeting the obligations under the contract exceed the economic benefits expected to be received under it, are recognised when it is probable that an outflow of resources embodying economic benefits will be required to settle a brsent obligation as a result of an obligating event based on a reliable estimate of such obligation. 1.18 Impairment of assets The Company assesses at each balance sheet date using external and internal sources, whether there is any indication that an asset or a group of assets comprising a cash-generating unit may be impaired. An impairment loss is recognized wherever the carrying value of an asset exceeds its recoverable amount. If any such indication exists, the Company estimates the recoverable amount of the asset. For an asset or group of assets that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs. If such recoverable amount of the asset or the recoverable amount of the cash-generating unit to which the asset belongs is less than its carrying amount, the carrying amount is reduced to its recoverable amount. The reduction is treated as an impairment loss and is recognised in the statement of profit and loss. If at the balance sheet date there is an indication that if a brviously assessed impairment loss no longer exists, the recoverable amount is reassessed and the asset is reflected at the recoverable amount subject to a maximum of debrciable historical cost. An impairment loss is reversed only to the extent that the carrying amount of asset does not exceed the net book value that would have been determined, if no impairment loss had been recognised. 1.19 Share and debenture issue expenses Share and debenture issue expenses are adjusted against the securities brmium account as permissible under Section 52 of the Companies Act, 2013, to the extent any balance is available for utilisation in the securities brmium account. 1.20Measurement of Earnings before Interest, Tax, Debrciation and Amortization As permitted by the Guidance Note on the Revised Schedule VI to the Companies Act, 1956 (which is considered to be applicable even in the context of schedule III to the Companies Act, 2013) the Company has elected to brsent earnings before interest, tax, debrciation and amortization (EBITDA) as a separate line item on the face of the statement of profit and loss. In its measurement of EBITDA, the Company includes other income but does not include debrciation and amortisation expense, finance costs, exceptional items and tax expense. 3 brPAID EXPENSES Prepaid expense to related party rebrsents rent paid to Asia Heart Foundation amounting to Rs. 258,142,612 (brvious year: Rs. 159,213,912). During the year ended 31 March 2016, the Company had entered into an agreement with Asia Heart Foundation to pay Rs. 108,908,592 by converting the future outflow of Rs. 1,000,000 p.m. towards discount entitlement of 214 months into brsent value. Against Rs. 108,908,592 the Company has paid Rs. 101,000,000till 31 March 2016. This is being amortized over the period of 214 months beginning from 1 April 2015. Prepaid expense includes rent paid to Modern Medical Institute amounting to Rs. 70,788,195 (brvious year: Rs. 75,413,195) which is being amortized over a period of 20 years from August 2011. 4 LEASES The Company has taken medical equipments, hospitals, office and residential brmises under cancellable operating lease agreements. The Company intends to renew such leases in the normal course of business. Total rental expenses under cancellable operating leases amounted to Rs. 216,759,149 for the year ended 31 March 2016 (brvious year: Rs. 191,930,854). 5 HOSPITAL MANAGEMENT FEES Hospital management fees rebrsents management fees paid under agreements entered into with certain trusts and companies, under which, the Company has a right over the management, operation and utilization of hospital facilities. 6 ADJUSTMENT OF SHARES AND DEBENTURES ISSUE EXPENSES WITH SECURITIES brMIUM During the financial year 2015-16, the Company paid fees amounting to Rs. 11,450,000 (brvious year Rs. 73,034,000) for professional services in connection with the funds raised from CDC Group PLC and CDC India Opportunities Limited. The same has been adjusted from securities brmium account as per Section 52(2) of the Companies Act, 2013. 6 INVESTMENT BY CDC IN EQUITY SHARES AND DEBENTURES During the financial year 2014-15, the Company had issued 20,339 equity shares of Rs. 10 each at a brmium of Rs. 98,326 per share to CDC Group PLC on 24 December 2014 (face value of Rs. 10 per share) aggregating Rs. 2,000,061,460. The Company had also issued 10,000,000, 10.50% optionally convertible debentures (OCD) aggregating Rs. 1,000,000,000 to CDC India Opportunities Limited : As per the amended agreement dated 25 September 2015, the above mentioned debentures are convertible as per the terms of the agreement. The shareholders of the Company in their meeting dated 1 December 2015, passed a resolution approving the conversion of OCDs along with accrued coupon into the said number of equity shares. Hence, the OCDs along with accrued interest got converted into 4,360,804 equity shares. 7 EARNINGS PER SHARE (EPS) Basic earnings per share The calculation of basic earnings per share for the year ended 31 March 2016 was based on profit attributable to equity shareholders of Rs. 567,771,648 (brvious year Rs. 210,021,079) and weighted average number of equity shares outstanding 201,453,601 (includes 2,040,000 equity shares with Narayana Health Employees Benefit Trust) (brvious year 190,910,293) (refer note 49). 8 CHANGE IN USEFUL LIFE OF FIXED ASSETS Pursuant to the notification of Schedule II to the Companies Act 2013, the Company in the financial year 2014-15, based on the internal technical evaluation, revised the estimated useful life of office equipments and electrical installations. The useful life of all other assets, other than the office equipment and electrical installation is unchanged. The amount adjusted through surplus (profit and loss balance), net of tax due to change in useful lives in the brvious year was Rs. 6,275,878. 9 BONUS SHARES During the financial year 2014-2015, the Company had issued 577.4476 fully paid up equity shares of Rs. 10 each for every 1 fully paid up equity share of Rs. 10 each to the existing shareholders whose name appeared in the register of members as on 25 March 2015, subject to the fractional shares being rounded off the nearest number. As per Section 63(1) of the Companies Act 2013, the bonus shares have been issued by utilising securities brmium account. The bonus shares rank pari passu in all respects including dividend with the existing equity shares of the Company. 10 SHAREHOLDERS AND INVESTMENT AGREEMENT Pursuant to the Shareholders and Investment Agreement dated 28 January 2008 (the agreement) entered amongst the Company; Ashoka Investments Holdings Private Limited, Ambadevi Mauritius Holdings Limited, JP Morgan Mauritius Holdings IV Limited (hereinafter collectively referred to as "Investors"); Dr. Devi Shetty and Mrs. Shakuntala Shetty, (hereinafter collectively referred to as 'Sponsors') and Narayana Health Academy Private Limited; the Investors invested in 75,414 equity shares (aggregates 43,623,049 equity shares including 43,547,635 bonus equity shares allotted on 25 March 2015). The terms of the agreement inter alia provided for certain exit options to the Investors before 4 August 2015. All the aforesaid parties have entered into an amendment agreement dated 16 July 2015 vide which the time to comply with the exit options was extended to 31 December 2015. The time limit to comply with the exit option was further extended to 31 January 2016 vide amended agreement dated 17 December 2015. The equity shares of the Company got listed on NSE and BSE on 6 January 2016. Hence, the Company has adhered to the time limits as per the Shareholders and Investment Agreement. 11 INVESTMENT IN NARAYANA HRUDAYALAYA HOSPITALS MALAYSIA SDN. BHD The Company has aggregate investment of Rs. 50,483,750 (brvious year: Rs. 105,695,250) in Narayana Hrudayalaya Hospitals Malaysia SDN. BHD ("NHHM"). The amount has been invested as Rs. 50,483,750 (brvious year: Rs. 50,483,750) in equity shares and Rs. Nil (brvious year: Rs. 55,211,500) in 6% partly convertible debentures. The 6% partly convertible debenture were redeemed during the current financial year. Based on the net assets of Narayana Hrudayalaya Hospitals Malaysia SDN. BHD as at 31 March 2016, the Company has recorded provision other than temporary diminution in the value of investment aggregating Rs. 32,953,428 (brvious year: Rs. 30,463,760). 12 DEBENTURE REDEMPTION RESERVE As per Section 71 of the Companies Act 2013, and Companies (Share Capital and Debenture) Rules, 2014 the Company, in the year 2014-2015 created Debenture Redemption Reserve (DRR) amounting to Rs. 250,000,000 for the purpose of redemption of debentures, which is 25 % of the value of the debentures issued. The DRR was created out of the profits of the company available for the payment of dividend. In the shareholders meeting on 1 December 2015, a resolution was passed approving the conversion of debentures into equity shares of the company. Hence the amount in the debenture redemption reserve has been transferred to the general reserve. 13 EMPLOYEE STOCK OPTION PLAN (ESOP) During the year ended 31 March 2016, the Company introduced the NH ESOP 2015 ("NH ESOP") for the benefit of the employees of the Company, its subsidiaries and an associates, as approved by the Board of Directors in its meeting held on 12 September 2015. NH ESOP 2015 provides for the creation and issue of 2,040,000 share options that would eventually convert into equity shares of Rs. 10 each in the hands of the employees of the Company, its subsidiaries and associate. The options are to be granted to the eligible employees as per the eligibility criteria as determined by the Nomination and Remuneration Committee at its sole discretion. The share options vest in a graded manner over a period of four years and are exercisable in one or more tranches within a period of four years from the date of first vesting, failing which the options shall lapse. Pursuant to NH ESOP, the Company granted 805,670 shares options till 31 March 2016 (brvious year: Nil). The Stock compensation cost is computed under the intrinsic value method. For the year ended 31 March 2016, the Company has recorded stock compensation expenses of Rs. 33,096,290 (brvious year: Nil). (b) Provision for bonus Exceptional item also rebrsents additional provision for bonus amounting to Rs. 12,472,983 for the period from 1 April 2014 to 31 March 2015 pursuant to the retrospective application of "The Payment of Bonus (Amendment) Act, 2015" effective 1 April 2014. The notes referred to above form an integral part of the financial statements As per our report of even date attached for and on behalf of the Board of Directors of For B S R & Co. LLP Chartered Accountants Firm's registration number : 101248W/W-100022 Amit Somani Partner Membership number: 60154 Narayana Hrudayalaya Limited (formerly known as Narayana Hrudayalaya Private Limited) Dr. Devi Prasad Shetty Chairman DIN: 00252187 Ashish Kumar Company Secretary Kesavan Venugopalan Chief Financial Officer Place: Bengaluru Date: 30 May 2016 |